Rediff.com  » Business » Sensex soars 500 points; Nifty at 11-month high

Sensex soars 500 points; Nifty at 11-month high

By Surabhi Roy
Last updated on: July 11, 2016 17:03 IST
Get Rediff News in your Inbox:

A market investor reacts

Tata Motors emerged as the top Sensex gainer up over 4%.

Benchmark indices ended higher by almost 2% with the Nifty50 index hitting the highest mark since August, 2015, supported by strong global cues as stronger-than-expected US jobs report suggested that recovery in the world's largest economy was back on track.

The S&P BSE Sensex zoomed 500 points to end at 27,627, the highest level in almost 9 months.

The Nifty50 surged 145 points to close the session at 8,468 after hitting an intra-day high of 8,475, its highest level since August 20, 2015.

In the broader market, the BSE Midcap index hit a record high of 12,079 and the NSE Midcap 100 hit 14,299.

Index of Industrial Production and inflation data, quarterly earnings from blue-chips TCS and Infosys and progress of monsoon rains will be key determinants for the stock market this week, say experts.

Asian and European markets enjoyed a relief rally on Monday as upbeat US jobs data lessened immediate concerns about the health of the world's largest economy, while the long-run fallout from Brexit kept sovereign yields near record lows.

MSCI's broadest index of Asia-Pacific shares outside Japan jumped 1.9% to a one-month top. Australia added 1.8% and Shanghai 1%. Japan's Nikkei climbed 3.5%, its biggest daily gain in three months, following a clear win by the government in upper house elections.

In Europe, CAC, DAX and FTSE surged between 0.6%-1.3%.

Back home, rupee traded higher by 20 paise at 67.16 against the US dollar today as exporters and banks stepped up selling of the American currency.

Barring Axis Bank, all the Sensex 30 stocks ended in positive zone. Shares of three private sector banks – HDFC Bank, IndusInd Bank and YES Bank –hit their respective lifetime highs on expectation of robust earnings for the first quarter (April –June) of the current financial year 2016-17.

IndusInd Bank slipped post the announcement of earnings for the first quarter.

Shares of non-banking financial companies were on a roll with most stocks hitting their respective 52-week highs on the BSE today.

Bajaj Finance, LIC Housing Finance, GIC Housing Finance, Bajaj Finserv and Mahindra & Mahindra Financial Services from the BSE500 index hit record highs, while Bharat Financial Inclusion (formerly SKS Microfinance), Gruh Finance and Shriram Transport Finance touched their multi-year highs on the BSE.

Bajaj Finance surged almost 5% after the company announced that its board will meet on July 26 to consider sub-division of equity shares of the company and bonus issue.

Tata Motors rose 4% after the company reported a 21% rise in its global wholesales at 92,551 units in June 2016 over June 2015.

BSE-NSE intraday tradingDomestic passenger vehicle sales grew 2.68% to 2,23,454 units in June from 2,17,620 units in the same month last year. However, car sales were down 5.18% to 1,54,237 units as against 1,62,655 units in June last year, according to data released by the Society of Indian Automobile Manufacturers (SIAM).

Maruti Suzuki gained almost 3%.

L&T Infotech hit the capital markets today to raise up to Rs 1,243 crore through an initial share sale offer. L&T surged almost 2%.

German conglomerate ThyssenKrupp on Saturday defended merger talks with Indian rival Tata Steel saying the consolidation of the sector in Europe was necessary due to the "difficult economic situation". Shares of Tata Steel shined 3%.

Private sector HDFC Bank plans to focus on digital platforms in rural and semi-urban markets to achieve sustained growth in the coming years. The stock was up 2%.

Dishman Pharmaceuticals & Chemicals gained by 3% after the company on Saturday announced inspection of its Bavla plant has been successfully completed by the United States Food and Drug Administration (USFDA).

Cadila Healthcare moved higher by 3.5% after the company announced that it has received final approval from the US drug regulator for an oral anti-diabetic drug.

Image: A market investor reacts. Photograph: Reuters

Get Rediff News in your Inbox:
Surabhi Roy in Mumbai
Source: source
SHARE THIS STORY 

Moneywiz Live!